)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Mindray
Mindray (300760) investor relations material
Mindray Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2026 earnings summary29 Oct, 2026
Executive summary
9M 2026 revenue was RMB 27.10bn, up 4.89% YoY; attributable net income was RMB 7.18bn, down 5.10%, and operating cash flow was RMB 8.30bn, up 14.08%.
At constant exchange rates, 9M revenue grew 7.38%; excluding FX effects, net income rose 6.29% and adjusted net income rose 8.83%.
Q3 revenue grew 2.85% YoY; attributable net income declined 4.55%, while adjusted attributable net income declined 1.62%.
Financial highlights
9M consolidated net income was RMB 7.56bn, down 3.19% YoY; adjusted consolidated net income was RMB 7.63bn, down 0.81%.
Q3 consolidated net income was RMB 2.52bn, down 2.47% YoY; adjusted consolidated net income was RMB 2.60bn, up 0.60%.
9M basic EPS was RMB 5.9285, down 5.12% YoY; attributable weighted average ROE was 17.80%, down 1.84 percentage points.
Period-end total assets were RMB 62.01bn, up 4.63% from year-end; equity attributable to shareholders was RMB 41.20bn, up 8.16%.
Outlook and guidance
Full-year international revenue is expected to sustain relatively fast growth, led by Europe, Latin America and Asia-Pacific, with international mix expected to rise further.
Domestic revenue is expected to return to growth in 2026; from 2027 onward, domestic business is expected to enter a sustained, steady high-quality growth phase.
International life information and support is expected to maintain steady, fast long-term growth; overseas medical imaging growth is targeted through premium ultrasound expansion.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Mindray
- Revenue up 6% to RMB 17.75B; international sales 53%; net profit down 5.37% year-over-year.300760
Q2 2026 - International growth offset domestic weakness as Q1 2026 revenue rose but net profit declined.300760Q1 2026
- 2025 net profit fell 30.28% as revenue declined, but international business grew to 53% of total.300760H2 2025
- Q3 revenue rebounded with international growth, but YTD net profit declined sharply.300760Q3 2025
- H1 2025 revenue and profit declined sharply, but international growth and digital transformation continue.300760H1 2025
- AI-powered, multi-disciplinary solutions drive efficiency and global expansion in healthcare.30076043rd Annual J.P. Morgan Healthcare Conference Presentation
- Revenue and profit rose 8% year-over-year, led by strong international growth.300760Q3 2024
- Double-digit profit and revenue growth, strong IVD, cardiovascular entry, high dividend.300760H1 2024
- International growth and strong dividends offset domestic softness; recovery expected.300760Q1 2025
Next Mindray earnings date
H2 202626 Apr, 2027
Mindray
Next Mindray earnings date
H2 202626 Apr, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Shenzhen Mindray Bio-Medical Electronics Co Ltd (Mindray) is a developer, manufacturer, and marketer of medical devices and solutions. The company's extensive product portfolio includes in-vitro diagnostics, patient monitoring and life support products, medical imaging systems, and products for orthopedics and veterinary care. Key offerings encompass patient monitoring systems, anesthesia machines, ventilators, electrocardiographs, defibrillators, surgical lights, operating tables, medical supply units, infusion pumps, endoscopes, and various accessories. Additionally, Mindray provides hematology and chemistry analyzers, chemiluminescence immunoassay products, and radiology and ultrasound products. The company is headquartered in Shenzhen, China, and its shares are listed on the Shenzhen Stock Exchange.